ethosuximide has been researched along with Mucopolysaccharidosis II in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Mucopolysaccharidosis II: Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At 7 years of age, a female with mucopolysaccharidosis type II (MPS II) showed a sudden deterioration in neurological function, a sleep disorder, and progressive behavioural impairment." | 5.38 | Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide. ( Bonanni, P; Boniver, C; Gubernale, M; Martinez, F; Martinuzzi, A; Milantoni, L; Randazzo, G; Scarpa, M; Vecchi, M, 2012) |
| "At 7 years of age, a female with mucopolysaccharidosis type II (MPS II) showed a sudden deterioration in neurological function, a sleep disorder, and progressive behavioural impairment." | 1.38 | Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide. ( Bonanni, P; Boniver, C; Gubernale, M; Martinez, F; Martinuzzi, A; Milantoni, L; Randazzo, G; Scarpa, M; Vecchi, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanni, P | 1 |
| Gubernale, M | 1 |
| Martinez, F | 1 |
| Randazzo, G | 1 |
| Milantoni, L | 1 |
| Martinuzzi, A | 1 |
| Boniver, C | 1 |
| Vecchi, M | 1 |
| Scarpa, M | 1 |
1 other study available for ethosuximide and Mucopolysaccharidosis II
| Article | Year |
|---|---|
Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide.
Topics: Anticonvulsants; Child; Child, Preschool; Disease Progression; Electroencephalography; Epilepsy, Fro | 2012 |